Attenuation Phenotype of a Cell Culture-Adapted Variant of Hepatitis A Virus (HM175/p16) in Susceptible New World Owl Monkeys

The virulence of a clonally isolated, cell culture-adapted hepatitis A virus (HM175/p16) was assessed in 4 seronegative owl monkeys inoculated intravenously with 2.8 × 104 radioimmunofocus- forming units of virus. The virus was highly attenuated, even though its complete nucleotide sequence contains...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 168; no. 3; pp. 592 - 601
Main Authors Taylor, Kerry L., Murphy, Paula C., Asher, Ludmila V. S., LeDuc, James W., Lemon, Stanley M.
Format Journal Article
LanguageEnglish
Published Chicago, IL The University of Chicago Press 01.09.1993
University of Chicago Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The virulence of a clonally isolated, cell culture-adapted hepatitis A virus (HM175/p16) was assessed in 4 seronegative owl monkeys inoculated intravenously with 2.8 × 104 radioimmunofocus- forming units of virus. The virus was highly attenuated, even though its complete nucleotide sequence contains only 19 mutations from the wild-type genome. Only 3 monkeys developed antibodies to hepatitis A virus (only 2 within 96 days of virus inoculation). One monkey had viremia and significantly elevated serum aminotransferase levels. In this animal, maximum viremia and fecal shedding of virus occurred 30–33 days after inoculation. In contrast, in earlier studies of a related cell culture-adapted but still hepatovirulent virus (HM175/S18), viremia was documented in 6 of6 animals and peak viremia and fecal shedding ofvirus occurred 18 or 19 days after intravenous inoculation of about one-tenth as much virus.
Bibliography:Reprints or correspondence: Dr. Stanley M. Lemon, 547 Burnett-Womack, CB# 7030, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7030.
ark:/67375/HXZ-TBB23H34-7
istex:7241FEB839C2BA74A16157B5ECEFBB93EAB71E6D
Present affiliation: Microbiology and Immunology Support Services, World Health Organization, Geneva.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0022-1899
1537-6613
DOI:10.1093/infdis/168.3.592